ENDOCRINE ASPECTS OF OBESITY

被引：12

作者：

DRENT, ML

VANDERVEEN, EA

机构：

[1] Department of Endocrinology, Free University Hospital, 1081 HV Amsterdam

来源：

NETHERLANDS JOURNAL OF MEDICINE | 1995年 / 47卷 / 03期

关键词：

OBESITY; ADRENAL HORMONES; GROWTH HORMONE; THYROID HORMONES; CATECHOLAMINES; PANCREAS HORMONES; GUT HORMONES;

D O I：

10.1016/0300-2977(95)00008-B

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A review is presented of the endocrine status in human obesity. The effect of changes in nutrient intake or body weight and the use of weight-reducing drugs on endocrine systems are discussed. There are several endocrine abnormalities found in obese patients. However, these altered endocrine functions seem secondary to the obese state and do not play a role in the pathogenesis of obesity. Some of these abnormalities are, at least partially, responsible for the development of complications related to the obese state. Weight reduction in general is followed by normalization of endocrine functions. The pharmacological agents used in the treatment of obesity do not influence the endocrine systems significantly.

引用

页码：127 / 136

页数：10

共 98 条

[81]

SCHTEINGART DE, 1963, METABOLISM, V12, P484

[82]

SCHWARTZ TW, 1983, GASTROENTEROLOGY, V85, P1411

[83] TEMPORAL CHANGES IN PROLACTIN AND CORTICOSTERONE RESPONSE DURING CHRONIC TREATMENT WITH D-FENFLURAMINE [J].